A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults.
Reuben N RobbinsHetta GouseHenry G BrownAndries EhlersTravis M ScottCheng-Shiun LeuRobert H RemienClaude A MellinsJohn A JoskaPublished in: JMIR mHealth and uHealth (2018)
NeuroScreen, a highly automated, easy-to-use, tablet-based screening test to detect NCI among English- and isiXhosa-speaking South African HIV patients demonstrated robust sensitivity and specificity to detect NCI when administered by lay health workers. NeuroScreen could help make screening for NCI more feasible. However, additional research is needed with larger samples and normative test performance data are needed.
Keyphrases
- hiv infected
- antiretroviral therapy
- end stage renal disease
- high throughput
- human immunodeficiency virus
- healthcare
- newly diagnosed
- chronic kidney disease
- ejection fraction
- hiv positive
- machine learning
- hepatitis c virus
- peritoneal dialysis
- mental health
- hiv testing
- bipolar disorder
- patient reported outcomes
- men who have sex with men
- south africa
- single cell
- human health